Randy Baker
Analyst · KeyBanc Capital Markets. You may proceed with your question.
Okay. So the Cortland Fibron business, which fell on that category one, that we talked about a year ago, it's taken some time to find an adequate owner for that particular company. It's one of the better plants that we owned. It was very, very well laid out, good equipment, good people, good technology, but in a rough industry. As you can see from our full-year guide, the total amount of dollars that has been pulled out of the top line, you can easily see that that was associated with Cortland Fibron. On the downside or good side, is that there's no fundamental impact to our EPS or full-year EBITDA, it's very, very small, in fact -- it's in fact, some negative on the operating profit line, so it actually helps us in the long run to eliminate, which was part of the reason why it was on our list. So, the proceeds on that along with the proceeds for the other businesses add into our already very strong liquidity and cash balance, which gives us even increased flexibility for some of our acquisition targets. Timing on the other two, certainly we're working those hard, you know, Fab, our General Counsel is right in the middle of both those particular deals, and we should be able to give you more guidance on that at our -- on our second quarter earnings call. Don't want to be predictive on it at this point, because you never know what can unfold, but we hope it moves sooner than later.